Adaptive Biotechnologies (ADPT) EBITDA Margin Growth (1y) (2019 - 2026)
Adaptive Biotechnologies (ADPT) EBITDA Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 50.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 519.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 1,012.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 376.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -101.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 136.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 93.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 352.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 92.00 |
| 10 | Adaptive Biotechnologies | 4.23 Bn | 3.89 Bn | 51.39 Mn | -1,173.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,173.00 |
| Mar 31, 2026 | 3,470.00 |
| Dec 31, 2025 | 3,669.00 |
| Sep 30, 2025 | 5,704.00 |
| Jun 30, 2025 | 3,211.00 |
| Mar 31, 2025 | 4,972.00 |
| Dec 31, 2024 | -311.00 |
| Sep 30, 2024 | 5,427.00 |
| Jun 30, 2024 | 27,990.00 |
| Mar 31, 2024 | 3,124.00 |
| Dec 31, 2023 | 4,924.00 |
| Sep 30, 2023 | 1,631.00 |
| Jun 30, 2023 | -20,207.00 |
| Mar 31, 2023 | 6,476.00 |
| Dec 31, 2022 | 9,140.00 |
| Sep 30, 2022 | 4,773.00 |
| Jun 30, 2022 | 899.00 |
| Mar 31, 2022 | -5,592.00 |
| Dec 31, 2021 | -1,583.00 |
| Sep 30, 2021 | -184.00 |